Clover Health Investments, Corp. (NASDAQ:CLOV – Get Free Report) CEO Brady Patrick Priest sold 98,039 shares of Clover Health Investments stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $3.52, for a total transaction of $345,097.28. Following the completion of the transaction, the chief executive officer directly owned 2,040,222 shares in the company, valued at approximately $7,181,581.44. This represents a 4.58% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Brady Patrick Priest also recently made the following trade(s):
- On Wednesday, March 4th, Brady Patrick Priest sold 175,000 shares of Clover Health Investments stock. The stock was sold at an average price of $2.17, for a total transaction of $379,750.00.
Clover Health Investments Trading Up 8.2%
Shares of CLOV stock opened at $3.55 on Thursday. Clover Health Investments, Corp. has a 1 year low of $1.58 and a 1 year high of $3.92. The firm’s fifty day simple moving average is $2.18 and its 200 day simple moving average is $2.40. The firm has a market capitalization of $1.86 billion, a P/E ratio of -29.58 and a beta of 2.44.
Institutional Trading of Clover Health Investments
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Sei Investments Co. increased its stake in shares of Clover Health Investments by 109.7% in the 1st quarter. Sei Investments Co. now owns 88,701 shares of the company’s stock valued at $156,000 after acquiring an additional 46,404 shares during the last quarter. State of Wyoming grew its position in shares of Clover Health Investments by 21.3% in the 1st quarter. State of Wyoming now owns 93,213 shares of the company’s stock valued at $164,000 after purchasing an additional 16,352 shares during the period. R Squared Ltd acquired a new position in shares of Clover Health Investments in the 1st quarter valued at approximately $66,000. Turtle Creek Wealth Advisors LLC grew its position in shares of Clover Health Investments by 29.4% in the 1st quarter. Turtle Creek Wealth Advisors LLC now owns 220,000 shares of the company’s stock valued at $387,000 after purchasing an additional 50,000 shares during the period. Finally, USAdvisors Wealth Management LLC grew its position in shares of Clover Health Investments by 40.0% in the 1st quarter. USAdvisors Wealth Management LLC now owns 35,000 shares of the company’s stock valued at $60,000 after purchasing an additional 10,000 shares during the period. 19.77% of the stock is owned by institutional investors.
Analysts Set New Price Targets
Several research analysts recently issued reports on CLOV shares. Canaccord Genuity Group reduced their price target on shares of Clover Health Investments from $3.70 to $3.20 and set a “buy” rating on the stock in a research report on Friday, March 20th. Wall Street Zen raised Clover Health Investments from a “sell” rating to a “hold” rating in a report on Sunday, February 15th. Leerink Partners dropped their price objective on Clover Health Investments from $3.00 to $2.50 and set a “market perform” rating for the company in a report on Thursday, March 5th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Clover Health Investments in a report on Friday, March 27th. One investment analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Clover Health Investments has an average rating of “Hold” and an average price target of $2.90.
Read Our Latest Report on CLOV
Clover Health Investments Company Profile
Clover Health Investments is a technology-driven healthcare company specializing in Medicare Advantage plans for senior populations. The company combines insurance coverage with a proprietary software platform to improve care coordination, outcomes tracking and cost management. By leveraging data analytics, Clover Health aims to deliver personalized care pathways and preventive interventions for its members.
At the core of Clover’s offering is its Clover Assistant platform, which aggregates clinical and claims data from multiple sources to create real-time insights for physicians and care teams.
Further Reading
- Five stocks we like better than Clover Health Investments
- Oklo Stock Could Be Ready for Another Massive Run
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.
